| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
1 Department of Vision Sciences, Glasgow Caledonian University, Glasgow, Scotland, UK
2 Department of Child Health, University of Glasgow, Royal Hospital for Sick Children, Glasgow, Scotland, UK
3 Department of Nursing and Midwifery, University of Stirling, Stirling, Scotland, UK
Correspondence to:
Correspondence to:
Dr Malcolm, Department of Nursing and Midwifery, University of Stirling, Stirling FK9 4LA, Scotland, UK;
gcl305{at}clinmed.gla.c.uk
Aim: To test the hypothesis that maternal docosahexaenoic acid (DHA) supplementation during pregnancy enhances maturation of the visual evoked potential (VEP) in healthy term infants.
Methods: One hundred women were supplemented with either fish oil capsules rich in DHA (n = 50) or placebo capsules (n = 50) from week 15 of pregnancy until delivery. Total fatty acids in red blood cells and plasma were measured at weeks 15, 28, and 40 of pregnancy and at delivery in umbilical cord blood. Infant visual pathway development was assessed using VEPs recorded to flash stimuli shortly after birth and to both flash and pattern-reversal stimuli at 50 and 66 weeks post-conceptional age (PCA).
Results: Maternal supplementation did not significantly elevate the level of DHA in umbilical cord blood. Moreover, there were no significant differences in any of the VEP measures observed between supplementation groups. However, maturity of the pattern-reversal VEP at 50 and 66 weeks PCA was associated with DHA status of the infants at birth. Infants with higher DHA status, both as a concentration and as a percentage of total fatty acids, showed shorter P100 peak latencies of the pattern-reversal VEP than those with lower DHA status.
Conclusions: Maternal DHA supplementation during pregnancy did not enhance VEP maturation in healthy term infants. However, these results show an association between the DHA status of infants at term and early postnatal development of the pattern-reversal VEP, suggesting that DHA status itself may influence maturation of the central visual pathways.
Keywords: development; docosahexaenoic acid; fatty acids; visual evoked potential
Abbreviations: DHA, docosahexaenoic acid; VEP, visual evoked potential; RBC, red blood cell; PCA, post-conceptional age; % TFA, percentage of total fatty acids; LCPUFA, long chain polyunsaturated fatty acid
This article has been cited by other articles:
|
|
 |
|
  I. B. Helland, L. Smith, B. Blomen, K. Saarem, O. D. Saugstad, and C. A. Drevon Effect of Supplementing Pregnant and Lactating Mothers With n-3 Very-Long-Chain Fatty Acids on Children's IQ and Body Mass Index at 7 Years of Age Pediatrics, August 1, 2008; 122(2): e472 - e479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M Innis and R. W Friesen Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants Am. J. Clinical Nutrition, March 1, 2008; 87(3): 548 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C King and M Fewtrell Fishing for brain power? Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2008; 93(1): F4 - F6. [Full Text] [PDF]
|
|
|
|
|
|
J A Dunstan, K Simmer, G Dixon, and S L Prescott Cognitive assessment of children at age 21/2 years after maternal fish oil supplementation in pregnancy: a randomised controlled trial Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2008; 93(1): F45 - F50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G Lemay, A. M Zivkovic, and J B. German Building the bridges to bioinformatics in nutrition research Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1261 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Dubnov-Raz, Y. Finkelstein, and G. Koren {omega}-3 fatty acid supplementation during pregnancy: For mother, baby, or neither? Can Fam Physician, May 1, 2007; 53(5): 817 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Innis Dietary (n-3) Fatty Acids and Brain Development J. Nutr., April 1, 2007; 137(4): 855 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Szajewska, A. Horvath, and B. Koletzko Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1337 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L Jensen Effects of n-3 fatty acids during pregnancy and lactation Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1452 - 1457S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L Jensen, R. G Voigt, T. C Prager, Y. L Zou, J K. Fraley, J. C Rozelle, M. R Turcich, A. M Llorente, R. E Anderson, and W. C Heird Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants Am. J. Clinical Nutrition, July 1, 2005; 82(1): 125 - 132. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |
